Kodu・Aktsiate loetelu・Ocugen Inc

Ocugen Inc

Suletud

1.32 -3.65

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.32

Max

1.37

Põhinäitajad
By Trading Economics
Sissetulek	-5.7M -25M
Müük	-45K 1.5M
Aktsiakasum	-0.07
Kasumimarginaal	-1,671.841
Töötajad	116
EBITDA	-2.5M -20M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+648.18% upside

Dividendid
By Acuity
Järgmine tulemuste avaldamine	4. nov 2026

Turustatistika
By TradingEconomics
Turukapital	45M 461M
Eelmine avamishind	4.97
Eelmine sulgemishind	1.32

Ocugen Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

28. aug 2026, 23:56 UTC

Shares of Astronics Corp were higher during after-market hours, despite earlier fluctuations. The stock remains near the lower end of its one-month trading range.

28. aug 2026, 23:56 UTC

Monro Inc shares are slightly higher in after-market hours, maintaining a position about 5% above the 20-day moving average. No specific news was identified.

28. aug 2026, 23:56 UTC

Williams-Sonoma Inc. shares are trading higher in after-market hours, recovering from earlier fluctuations amid rising interest rate hike expectations.

28. aug 2026, 23:56 UTC

Zillow Group Inc shares are lower in after-market trading. Broader market conditions reflect increased expectations for an interest rate hike.

28. aug 2026, 23:56 UTC

Sana Biotechnology Inc. shares advanced modestly higher in after-market trading, remaining near the upper end of their one-month range.

28. aug 2026, 23:56 UTC

News

nVent Electric PLC will acquire Maverick Power for $1.75 billion, with additional performance-based payments. Shares are higher during after-market hours following the announcement.

28. aug 2026, 23:56 UTC

Shoals Technologies Group Inc. shares are higher in after-market trading, rebounding from earlier session lows, though still below the 20-day moving average.

28. aug 2026, 23:56 UTC

Pool Corp shares are higher in after-market trading, though no specific news explains the movement. Broader market dynamics may be influencing trading activity.

28. aug 2026, 23:56 UTC

Amgen Inc shares are lower in after-market hours, continuing a trend of declines after four consecutive sessions of lower finishes. No specific news was identified.

28. aug 2026, 23:56 UTC

Archer-Daniels-Midland Co shares are higher in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

28. aug 2026, 23:56 UTC

CareDx Inc shares are higher in after-market hours, reflecting a generally strong performance backdrop amid rising market expectations for a potential interest rate hike.

28. aug 2026, 23:52 UTC

Brazil's Q2 GDP Growth Rate Release on September 1, 2026, Faces Mixed Expectations Amid Inflation and High Interest Rates Concerns.

28. aug 2026, 23:52 UTC

Market Anticipation Rises for Interest Rate Hike Following Fed Chair Warsh's Hawkish Remarks on Inflation at Jackson Hole Symposium

28. aug 2026, 23:52 UTC

South Africa's Balance of Trade Report on August 31, 2026, Expected to Reflect Continued Fluctuations Amidst Recent Surplus and Easing Inflation Pressures.

28. aug 2026, 23:51 UTC

Macro Event

Macro News

Ethereum is trading lower as hawkish remarks from Fed Chairman Warsh raise inflation concerns. The Michigan Consumer Sentiment index also reported a decline.

28. aug 2026, 23:51 UTC

Mid-America Apartment Communities shares are lower in after-market hours as rising interest rate expectations pressure investor sentiment and contribute to the stock's decline.

28. aug 2026, 23:51 UTC

Revolve Group Inc shares are higher in after-market trading, reflecting a notable rise since Friday's close amid increased market expectations for a rate hike.

28. aug 2026, 23:51 UTC

Constellation Energy shares higher in after-market trading, maintaining a steady upward trajectory near the upper end of its one-month range. No specific news identified.

28. aug 2026, 23:51 UTC

Starbucks Corp shares rose in after-market trading, supported by increased market expectations for a rate hike next month. The stock reached a high during this session.

28. aug 2026, 23:51 UTC

Global equity markets rise as Fed's Warsh signals potential interest rate hike amid persistent inflation concerns, while U.S. consumer sentiment dips and Canadian GDP growth falls short of expectations.

28. aug 2026, 23:51 UTC

US equity markets remain flat as investors react to hawkish signals from Fed Chair Warsh's Jackson Hole speech, raising interest rate hike expectations and impacting bond yields and tech stocks.

28. aug 2026, 23:51 UTC

Asia equity markets rise ahead of Fed Chair Warsh's hawkish speech, signaling potential interest rate hikes amid persistent inflation concerns.

28. aug 2026, 23:51 UTC

European equities rise as strong Euro Area sentiment data and hawkish Fed signals boost interest rate hike expectations amid mixed labor market and inflation concerns.

28. aug 2026, 23:51 UTC

Applied Industrial Technologies Inc shares rose in after-market trading, recovering from earlier losses amid rising market expectations for a rate hike next month.

28. aug 2026, 23:51 UTC

Vanguard Mortgage-Backed Securities ETF is trading higher after the market closed, despite some volatility and no specific news to explain the movement.

28. aug 2026, 23:51 UTC

Social Media

CACI shares are lower in after-market hours following a Supreme Court ruling that overturned a previous verdict related to the company's liability for torture at Abu Ghraib.

28. aug 2026, 23:51 UTC

N-Able Inc shares are lower in after-market hours, with no specific news identified. Increased market expectations for a rate hike may be influencing the decline.

28. aug 2026, 23:51 UTC

Citizens Financial Group Inc shares are lower in after-market hours, reflecting broader market trends amid rising expectations for a rate hike and higher Treasury yields.

28. aug 2026, 23:51 UTC

Tower Semiconductor Ltd is gaining in after-market trading, reflecting a notable uptick since Friday's close, despite three consecutive lower daily finishes.

28. aug 2026, 23:51 UTC

Autodesk Inc shares declined in after-market trading, reaching a low of -0.56%. No specific company news was identified for the movement.

Võrdlus sarnastega

Hinnamuutus

Ocugen Inc Prognoos

Hinnasiht

By TipRanks

648.18% tõus

12 kuu keskmine prognoos

Keskmine 10.25 USD 648.18%

Kõrge 12 USD

Madal 8 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Ocugen Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Ocugen Inc aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.